SCHEMBL2949475

SCHEMBL2949475

FC(F)(F)c1ccccc1O[C@H]1CCN(c2nnc(-c3nn[nH]n3)s2)C1

nearest known ligand 0.89

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SCD O00767 11/20 0.60
LIPG Q9Y5X9 1/20 0.47
RBP4 P02753 1/20 0.46
TTR P02766 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473002 0.94 SCD (0.67) SCD
SCHEMBL2946892 0.85 SCD (0.71) SCDLIPG
SCHEMBL2951628 0.81 SCD (0.89) SCDLIPG
SCHEMBL2951285 0.81 SCD (0.67) SCDTTR
SCHEMBL2946945 0.80 SCD (0.78) SCDLIPG
SCHEMBL13870679 0.79 SCD (0.68) SCD
SCHEMBL2946848 0.79 SCD (0.68) SCDTTR
SCHEMBL2941842 0.77 SCD (0.58) SCDTTR
SCHEMBL4093049 0.76 SCD (0.75) SCD
SCHEMBL473046 0.75 SCD (1.00) SCDLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754745-B2 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase MERCK FROSST CANADA LTD. (CA) 2010-07-13 US disclosed
US-7754745-B2 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase MERCK FROSST CANADA LTD. (CA) 2010-07-13 US disclosed
US-7754745-B2 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase MERCK FROSST CANADA LTD. (CA) 2010-07-13 US disclosed
US-20090093527-A1 Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase MERCK FROSST CANADA LTD. (CA) 2009-04-09 US disclosed
US-20090093527-A1 Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase MERCK FROSST CANADA LTD. (CA) 2009-04-09 US disclosed
US-20090093527-A1 Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase MERCK FROSST CANADA LTD. (CA) 2009-04-09 US disclosed
WO-2007143824-A1 AZACYCLOPENTANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093527-A1 Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase SCD, SCD5, SREBF1 SCD 1/4885LIPG 200/4885RBP4 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.